Theranostics announced that the Phase 2b trial evaluating RAD101 imaging in brain metastases has achieved 50% patient enrollment ...
Early patient data from Phase 2b clinical trial showed significant and selective tumor uptake in brain metastases compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback